| abstract |
The present invention relates to the use of at least one compound selected from a compound of the formula 1a, 1b DOLLAR F1 a physiologically acceptable salt thereof or a stereoisomeric form thereof, wherein DOLLAR AR · 1 · H or alkyl, DOLLAR AR · 2 · H, COOH , COO-alkyl or CO-NH-R · 5 ·, DOLLAR AR · 3 · and R · 4 · each independently H or OH, DOLLAR A n 1, 2 or 3, DOLLAR AR · 5 · H, alkyl, a Amino acid residue, dipeptide residue or tripeptide residue and DOLLAR A alkyl an alkyl residue with 1 to 4 carbon atoms DOLLAR A, DOLLAR A for the prophylaxis and / or treatment of UV-induced immunosuppression. DOLLAR A These compounds are used according to the invention usually in the form of a topical composition. |